As gene therapy sales sputter, one biotech aims to defy the odds
With a strong launch underway for a bladder cancer gene therapy, Ferring Pharmaceuticals is finding the kind of commercial success that’s eluded many of its peers.
Previous Post
NHS talking therapies may be less effective in 16-24-year-olds
Next Post
This Week on NeurologyLive® — August 11, 2025
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago